Algebris (Uk) LTD Genenta Science S.P.A. Transaction History
Algebris (Uk) LTD
- $744 Million
- Q3 2025
A detailed history of Algebris (Uk) LTD transactions in Genenta Science S.P.A. stock. As of the latest transaction made, Algebris (Uk) LTD holds 100,000 shares of GNTA stock, worth $220,000. This represents 0.04% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$220,000
Previous $305,000
5.25%
% of portfolio
0.04%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding GNTA
# of Institutions
8Shares Held
555KCall Options Held
0Put Options Held
0-
Allianz Se Munich, 2M234KShares$514,9100.02% of portfolio
-
Al Ti Global, Inc. New York, NY200KShares$440,6330.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.5KShares$27,4690.0% of portfolio
-
National Bank Of Canada3KShares$6,6000.0% of portfolio
-
Gamma Investing LLC Foster City, CA2.83KShares$6,2190.0% of portfolio
About Genenta Science S.p.A.
- Ticker GNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,216,900
- Market Cap $40.1M
- Description
- Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...